Decline depth
-30.1%
From rolling 252-day high of $117.72, 128d ago.
Past the 30% Amber threshold.
Amber List
LMATLeMaitre Vascular, Inc.
Healthcare · Medical Instruments & Supplies · small-cap ($1.9B)
-30.1%
from rolling 252-day high of $117.72 set 2026-04-14 · 128d ago
Current
$82.32
Decline depth
-30.1%
Decline σ
3.8σ
TFC
0/5 bearish
Rolling 252-day high
Up day
Down day
Last 90 trading days · data from Alpaca
Since it joined the list
$LMAT landed on the list 2026-06-01, down 22.5% from its 52-week high that day — now down -30.1%.
That's 8.1 percentage points deeper than the day it joined.
Decline from the 52-week high as it stood on 2026-06-01 (fixed anchor) → today. Split-adjusted, Alpaca. Observed history, not a forecast.
Structural break signals
LMAT qualifies for the Amber List on decline depth.
Time-frame continuity
0/5 bearish
Latest bar across daily/weekly/monthly/quarterly/yearly time frames. A bar counts as bearish when it's a 2-Down or a red 3.
Decline sigma
3.8σ
Drop from local high over the last 20 bars, expressed in units of the stock's typical daily volatility (6.06% per day).
The structural read
What price action says about LMAT.
LMAT qualifies for the Amber List on decline depth — down -30.1% from its rolling 252-day high.
Upstream TFC read: weak alignment, current phase weekly. Last bar types — daily 1 (red), weekly 2U (green), monthly 3 (red).
Earnings on file: 2026-08-04. Tiering is unaffected by earnings dates — listings reflect price structure only.
Questions about LMAT
What people ask.
Why is LMAT on Broken Stocks?
LMAT qualifies for the Amber List on decline depth. It is down -30.1% from its rolling 252-day high of $117.72, set on 2026-04-14 — 128d ago.
Is LMAT a falling knife?
Not by the strict technical definition. LMAT is down -30.1% from its 52-week high, but that high was set 128d ago — more than 120 days. A falling knife is usually a recent breakdown from a fresh high, not an established multi-quarter downtrend. LMAT is still on the Amber List for decline depth, but the freshness component of a falling knife is missing.
Is LMAT a buy?
Broken Stocks does not issue buy or sell recommendations. The list is a rules-based technical warning system. It tracks structural decline depth and recency — not company quality, management, fundamentals, or news. Always do your own research and consult a licensed advisor.
Where is LMAT trading inside its 52-week range?
At $82.32, LMAT sits 9.3% of the way from its 52-week low ($78.65) to its 52-week high ($118.01). A reading below 25% indicates price is hugging the bottom of the range; above 75%, the top.
How fast has LMAT been declining?
The current 30.1% decline accrued over 128d, which annualizes to roughly -85.8% per year. Annualized pace is a sanity check — a 30% decline in three months is a different signal than a 30% decline over two years.
How does LMAT compare to its sector?
There are 143 other Healthcare tickers on Broken Stocks: 70 Red, 34 Amber, 39 Watch, with 50 showing recovering structural signals. Median sector decline is -36.1% — LMAT's decline is shallower than the sector median.
Does LMAT's earnings date affect its tier?
No. Tiering is decided purely by decline depth and recency of the rolling-high date. The earnings date on file (2026-08-04) is shown for reference only — listings can move tier between scans based on closing prices, regardless of fundamentals or news events.